• Explore /
  • Poster
  • / A multicenter phase II study of nivolumab +/- ipilimumab for patients with metastatic sarcoma (Alliance A091401): Results of expansion cohorts.

A multicenter phase II study of nivolumab +/- ipilimumab for patients with metastatic sarcoma (Alliance A091401): Results of expansion cohorts.

Abstract Poster

Authors

null

James Lin Chen

The Ohio State University, Columbus, OH

James Lin Chen , Michelle R. Mahoney , Suzanne George , Cristina R. Antonescu , David A. Liebner , Brian Andrew Van Tine , Mohammed M. Milhem , William D. Tap , Howard Streicher , Gary K. Schwartz , Sandra P. D'Angelo

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Discussion Session

Session Title

Sarcoma

Track

Sarcoma

Sub Track

Soft Tissue Tumors

Clinical Trial Registration Number

NCT02500797

Citation

J Clin Oncol 38: 2020 (suppl; abstr 11511)

DOI

10.1200/JCO.2020.38.15_suppl.11511

Abstract #

11511

Poster Bd #

399

Abstract Disclosures

Similar Posters

First Author: Geoffrey Thomas Gibney

Poster

2019 ASCO Annual Meeting

Phase II study of ipilimumab and nivolumab (ipi/nivo) in metastatic uveal melanoma (UM).

Phase II study of ipilimumab and nivolumab (ipi/nivo) in metastatic uveal melanoma (UM).

First Author: Meredith Pelster

First Author: Rohit K. Jain

First Author: Young Kwang Chae